Thoracic and GI Oncology Conference (Attendee Information)
This site is intended for registered participants of the 18th Annual Fall Midwest Thoracic and GI Oncology Conference (Sept. 7-8, 2023).
Welcome! Thank you for joining us.
This conference will explore treatment options available for the management of thoracic and GI cancers. This year's conference themes:
- Thoracic Sessions: Updates in the Management of Lung Cancer
- GI Sessions: Closing the Disparity Gap
Conference General Information
Thursday-Friday, Sept. 7-8
Read the UNMC CCE Disclosure Declaration Policy
Disclosures
The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles.
FACULTY
The following have disclosed relevant financial relationships:
- Malcolm M. DeCamp, MD
Consultant, DSMB Member: Pulmonx Corporation
Scientific Advisory Board: Pleural Dynamics - Emily Kathol, PharmD, BCOP
INVESTIGATIONAL/OFF-LABEL USE OF DRUGS DISCLOSURE: Abatacept, IVIG, alemtuzumab, infliximab, mycophenolate, cyclosporine, dupilumab, omalizumab, vedolizumab, tofacitinib, ustekinumab, DMARDs, TNF inhibitors, tocilizumab, and other steroid-sparing immunosuppressants for management of immune-related side effects - Kelsey Klute, MD
INVESTIGATIONAL/OFF-LABEL USE OF DRUGS DISCLOSURE: Various ctDNA assays for monitoring disease response, detecting the presence of microscopic residual disease - will not make clinical recommendations regarding off-label use, but will discuss existing data and strengths/limitations as well as personal experience - Mokenge Malafa, MD
INVESTIGATIONAL/OFF-LABEL USE OF DRUGS DISCLOSURE: Vitami E Delta Tocotrienol as a clinical trial agent - Bradley N. Reames, MD, MS, FACS
Consultant: Boston Scientific Corporation - Benjamin Swanson, MD, PhD
Scientific Advisory Board, Stock Ownership: Cogen Bioscience, Inc.
Speaker: France Foundation - Chi (Kevin) Zhang, MD, PhD
Research Grant: AstraZeneca
Travel Support: GT Medical Technologies, Inc.
The following have nothing to disclose:
- Omar Abughanimeh, MBBS
- Madhuri Are, MD
- David Berkheim, MD
- Sierra Clark, MGC, CGC
- Jason Foster, MD
- Martin Goodenberger, MD
- Jean Grem, MD
- Kathryn Hutchins, MD
- Rudy P. Lackner, MD, FACS, FCCP*
- Erik Lewis, MD
- Quan P. Ly, MD, FACS*
- Lucy Muinov, MD
- James Padussis, MD
- Rachael Schmidt, DNP, FNP-C, AOCNP
- Michelle Spink, RD, LMNT
- Laura Tenner, MD, MPH
- Lei Yu, MD
- Weining (Ken) Zhen, MD, FACR, FASTRO
PLANNING COMMITTEE
The following have nothing to disclose:
- Kelly Caverzagie, MD, FACP, FHM
- Missy Edwards
- Julie Huglin
- Brenda Ram, CMP, CHCP
- Jacqueline Siebels, BSN, RN, NPD-BC
*Faculty and planning committee member
The following materials (in PDF) are available for download until Sept. 27, 2023. No part of these materials may be reproduced without prior written permission.
Thoracic
- Ordering Advanced Thoracic Imaging: What Your Radiologist Wishes You Knew
Martin Goodenberger, MD - Update on Lung Cancer Screening
Rudy P. Lackner, MD, FACS, FCCP - Do Randomized Clinical Trials Really Change Practice: A Cautionary Tale
Malcolm DeCamp, MD - Neo-Adjuvant Immunotherapy for Early-Stage Non-Small Cell Lung Cancer
Omar Abughanimeh, MBBS - Dose Escalation of Radiation Therapy for Stage III Non-Small Cell Lung Cancer in the Era of Immunotherapy
Chi (Kevin) Zhang, MD, PhD - Understanding Radiation Pneumonitis: Causes, Symptoms and Treatment
Weining (Ken) Zhen, MD, FACR, FASTRO - Management of Hilar Node-Positive (N1) Non-Small Cell Lung Cancer
David Berkheim, MD - Sub-Lobar Resection for Early-Stage Non-Small Cell Lung Cancer: Clinical Evidence and Technical Considerations
Erik Lewis, MD
GI
- Whole-Body Magnetic Resonance Imaging (MRI) and Other Screening Exams for Cancer Detection
Lucy Muinov, MD and Martin Goodenberger, MD - Emerging Therapies for Colorectal Cancer
Jean Grem, MD - The Role of Hyperthermic Intraperitoneal Chemotherapy in Colorectal Cancer
Jason Foster, MD - Multidisciplinary Clinic for High-Risk Gastrointestinal (GI) Cancers
Rachael Schmidt, DNP, FNP-C, AOCNP and Kathryn Hutchins, MD - Liquid Biopsy: Ready for Prime Time?
Kelsey Klute, MD - Cancer Pain Management
Madhuri Are, MD - Prevention of Pancreatic Cancer by Targeting Pancreatic Neoplastic Cysts
Mokenge Malafa, MD - Research Opportunities in GI Cancer
Laura Tenner, MD, MPH - Pancreatic Cysts: From Cytology to Molecular
Benjamin Swanson, MD, PhD - The Role of Interventional Radiology in the Management of GI Cancers
Lei Yu, MD - Modifying Tastes and Smell of Food During Chemotherapy
Michelle Spink, RD, LMNT - Prevention, Risk Reduction, and Screening for Inherited Pancreatic Cancer
Sierra Clark, MGC, CGC - Palliative Surgery for Oncology Patients
James Padussis, MD - Now We’ve Got Problems: Immunotherapy-Related Adverse Events
Emily Kathol, PharmD, BCOP - Surgical Management of Pancreatic Oligometastasis: Are We There Yet?
Bradley Reames, MD, MS, FACS
Requirements for Successful Completion
In order to receive continuing education credits, you must:
- Check in at the registration desk and attend the live activity.
- Complete the online evaluation via the UNMC MyCCE portal.
- On your dashboard, click Evaluate an Activity.
- Enter Activity Code:
57875 – if you are attending the full conference
57877 – if you are attending the Thoracic Session (Thursday) only57879 – if you are attending the GI Session (Friday) only
You have until Sept. 27, 2023, to claim credit for this activity. You will need to complete the evaluation and attest to the time you spent participating in the activity. Your certificate will be saved in your UNMC MyCCE account under Certificates & Transcripts.
Need help managing your MyCCE account? Find answers to commonly asked questions about signing in to the portal, completing the online evaluation, retrieving your certificate, and more. Go to Manage MyCCE Account
Conference Directors
Professor of Surgery; Chief, Section of Thoracic Surgery; Vice Chief and Director of Residency Program, Division of Cardiothoracic Surgery, Department of Surgery, UNMC
Professor, Division of Surgical Oncology; Vice Chair of Diversity, Equity and Inclusion, Department of Surgery; Associate Director of Diversity, Equity and Inclusion, Fred & Pamela Buffett Cancer Center, UNMC
Nebraska State Chair, Commission on Cancer, American College of Surgeons
Questions?
Educational Projects Coordinator
UNMC Center for Continuing Education
